Dendrophryniscus is an early diverging clade of bufonids represented by few small-bodied species distributed in Amazonia and the Atlantic Forest. We used mitochondrial (414 bp of 12S, 575 bp of 16S genes) and nuclear DNA (785 bp of RAG-1) to investigate phylogenetic relationships and the timing of diversification within the genus. These molecular data were gathered from 23 specimens from 19 populations, including eight out of the 10 nominal species of the genus as well as Rhinella boulengeri. Analyses also included sequences of representatives of 18 other bufonid genera that were publically available. We also examined morphological characters to analyze differences within Dendrophryniscus. We found deep genetic divergence between an Amazonian and an Atlantic Forest clade, dating back to Eocene. Morphological data corroborate this distinction. We thus propose to assign the Amazonian species to a new genus, Amazonella. The species currently named R. boulengeri, which has been previously assigned to the genus Rhamphophryne, is shown to be closely related to Dendrophryniscus species. Our findings illustrate cryptic trends in bufonid morphological evolution, and point to a deep history of persistence and diversification within the Amazonian and Atlantic rainforests. We discuss our results in light of available paleoecological data and the biogeographic patterns observed in other similarly distributed groups.
OBJECTIVE:Depression is the most important neuropsychiatric complication in chronic kidney disease because it reduces quality of life and increases mortality. Evidence demonstrating the association between dialysis shift and depression is lacking; thus, obtaining such evidence was the main objective of this study.METHOD:This cross-sectional study included patients attending a hemodialysis program. Depression was diagnosed using Beck's Depression Inventory. Excessive daytime sleepiness was evaluated using the Epworth Sleepiness Scale.RESULTS:A total of 96 patients were enrolled (55 males, age 48±14 years). Depression and excessive daytime sleepiness were observed in 42.7% and 49% of the patients, respectively. When comparing variables among the three dialysis shifts, there were no differences in age, dialysis vintage, employment status, excessive daytime sleepiness, hemoglobin, phosphorus levels, or albumin levels. Patients in the morning shift were more likely to live in rural areas (p<0.0001), although patients in rural areas did not have a higher prevalence of depression (p = 0.30). Patients with depression were more likely to be dialyzed during the morning shift (p = 0.008). Independent risk factors for depression were age (p<0.03), lower levels of hemoglobin (p<0.01) and phosphorus (p<0.01), and dialysis during the morning shift (p = 0.0009). The hospitalization risk of depressive patients was 4.5 times higher than that of nondepressive patients (p<0.008).CONCLUSION:These data suggest that depression is associated with dialysis shift, higher levels of phosphorus, and lower levels of hemoglobin. The results highlight the need for randomized trials to determine whether this association occurs by chance or whether circadian rhythm disorders may play a role.
We revisit species diversity within Oreobates (Anura: Strabomantidae) by combining molecular phylogenetic analyses of the 16S rRNA amphibian barcode fragment with the study of the external morphology of living and preserved specimens. Molecular and morphological evidence support the existence of 23 species within Oreobates, and three additional candidate species (Oreobates sp.
Leposoma sinepollex sp. nov., a new species of the scincoides group, is described from a mountain region in the Atlantic Forest central corridor in state of Bahia, Brazil. The new species is characterized by elongate dorsal and lanceolate ventral scales arranged in diagonal rows, a single and smooth frontonasal, five supraoculars, absence of pollex, third toe as long as or longer than fourth, absence of striations in lower part of head, parietals longer than wide and as long as interparietal, 27–29 dorsals, 25–29 scales around body, 17–19 ventrals, 12–14 total pores in the male (absent in females), 9–10 and 9–11 subdigital lamellae respectively under IV Finger and IV Toe, and strong sexual color dichromatism with a black pigmentation in the ventral parts of males, creamy in females. The new species is morphologically similar to Leposoma nanodactylus, sharing with it among other features the synapomorphic division of the first supraocular. Phylogenetic analyses of 981 bp of combined sequences (cyt b+ ND4) recovered also a strongly supported (PP=1,0; BP=100) sister relationship between both species. The new species and Leposoma nanodactylus are placed sister to all the other Atlantic Forest species, with L. baturitensis being the first to diverge in this radiation. We discuss the distribution of the Atlantic Forest Leposoma, as well as possible scenarios for the origin of the new species.
We describe a new species of whiptail lizard genus Ameivula from Planalto dos Gerais, a sandstone plateau that extends along the Cerrado region in the states of Bahia, Tocantins, Piaui, and Minas Gerais, in Brazil. The new species is the third recognized speeies of the A. oeellifera group registered for the Cerrado. Quantitative analyses of morphometrie characters showed that Caatinga species are distinguished from their Cerrado congeners on basis of body size and shape. A discriminant analysis upon meristic characters showed that the new species can be clearly distinguished from the other two Cerrado speeies A. mumbuca and A. jalapensis, also the morphology of the finger lamellae, and clutch size distinguish these species.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.